- 2026-03-18 13:36AZD-CO-Ph-PEG4-Ph-CO-AZD 2569143-72-0
- 2026-03-18 13:36Axitinib analogue 1 319463-51-9
- 2026-03-18 13:36AWL-II-38.3 1135205-94-5
- 2026-03-18 13:36Avenciguat (BI-685509) 1579514-06-9
- 2026-03-18 13:36AU-16235 2380275-40-9
- 2026-03-18 13:36ATV041 2935937-67-8
- 2026-03-18 13:36ATUX-1215 2910929-53-0
- 2026-03-18 13:36ATR-IN-9 2417513-43-8
- 2026-03-18 13:36AtPCO4-IN-1 316134-38-0
- 2026-03-18 13:36Atinvicitinib 2169273-59-8
- 2026-03-18 13:36ATIC-IN-1 1402453-15-9
- 2026-03-18 13:36ASN04421891 570365-12-7
- 2026-03-18 13:35ASN 07115873 626220-97-1
- 2026-03-18 13:35ASGPRligand-1 1426160-58-8
- 2026-03-18 13:35Asfotase alfa (ENB-0040) 1174277-80-5
- 2026-03-18 13:35Ascr#7 1139837-37-8
- 2026-03-18 13:35ARUK2001607 2924824-56-4
- 2026-03-18 13:35ARN19689 2320521-34-2
- 2026-03-18 13:35ARN14988 1502027-70-4
- 2026-03-18 13:35ARN 077 (enantiomer) (URB913 (enantiomer)) 1439366-88-7
